Kandi Technologies Group, Inc. Ordinary Shares (KNDI) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, KNDI trades at $0.71 with a market cap of $66.00M and a P/E ratio of 35.25. KNDI moved +5.63% today. Year to date, KNDI is -22.17%; over the trailing twelve months it is -39.97%. Its 52-week range spans $0.61 to $2.07. Rallies surfaces KNDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading KNDI stock inside the company?
Recent KNDI insider activity includes Yu Henry sold 4.01K, Yu Henry sold 4.00K, Wang Lin sold 1.00K, Yu Henry sold 4.33K, and Sun Chenming sold 13.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
KNDI Key Metrics
Key financial metrics for KNDI
Metric
Value
Price
$0.71
Market Cap
$66.00M
P/E Ratio
35.25
EPS
$0.02
Dividend Yield
0.00%
52-Week High
$2.07
52-Week Low
$0.61
Volume
1.11K
Avg Volume
0
Revenue (TTM)
$123.60M
Net Income
$1.67M
Gross Margin
33.47%
Recent KNDI Insider Trades
Yu Henry sold 4.01K (~$15.24K) on Nov 26, 2021.
Yu Henry sold 4.00K (~$16.10K) on Nov 24, 2021.
Wang Lin sold 1.00K (~$15.00K) on Nov 25, 2020.
Yu Henry sold 4.33K (~$55.85K) on Nov 19, 2020.
Sun Chenming sold 13.00K (~$143.26K) on Nov 18, 2020.
KNDI analyst coverage data. Average price target: $0.00.
Common questions about KNDI
Who is trading KNDI stock inside the company?
Recent KNDI insider activity includes Yu Henry sold 4.01K, Yu Henry sold 4.00K, Wang Lin sold 1.00K, Yu Henry sold 4.33K, and Sun Chenming sold 13.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for KNDI?
Yes. Rallies tracks KNDI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is KNDI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KNDI. It does not provide personalized investment advice.